Nirmal Raut· @oncologician · X·· 1 day agoScore45
Body
Solid tumour oncologists will now have to get used to tongue twisters like "Izalontamab Brengitecan" like heamtologists pronouncing "Axicabtagene ciloleucel"
#ESMO2026 @BalazsHalmosMD
16 views · 0 likes · 0 reposts · 0 replies
Conference abstracts
Phase II study of izalontamab brengitecan (Iza-bren) plus osimertinib in patients with EGFR mutant locally advanced or metastatic non-small cell lung cancer (NSCLC)
https://esmocongress.esmo.orgLBA50matched by Proffered paper 1: Breast cancer, early and advanced stage
PANKU-Breast01: Randomized phase III study of izalontamab brengitecan (iza-bren) in previously treated unresectable locally advanced or metastatic (LA/M) hormone receptor-positive/HER2-negative (HR+/HER2-) breast cancer (BC)
https://esmocongress.esmo.orgSource: Nirmal Raut · x.com